The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
The discovery and development of HMG-CoA reductase inhibitors.
Open accessAbstract
During the 1950s and 1960s, many cholesterol-lowering agents were reported and introduced into clinical use, in-
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, TGs have been demonstrated to be correlated with acute pancreatitis655).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [655]
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775
Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630
Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Self-citationEndo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800
Self-citationHMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760
Influence of nicotinic acid on serum cholesterol in man
Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726
Research works printed but not linked: 5
- 1988, The Lipid Research Clinics Coronary Primary Prevention Trial Results. 1. Reduction in the incidence of coronary heart disease, JAMA., 251, 351
- Taupitz, 1959, The effects of estrogens on the serum cholesterol of male rats, Symp. Deut. Ges. En-dokrinol., 430
- Endo, 1978, Effects of ML-236B, a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase, on cholesterol metabolism, Adv. Exp. Med. Biol., 109, 376
- Shigematsu, 1979, Treatment of hypercholesterolemia with an HMG-CoA reductase inhibitor (CS-500). I. Phase I study in normal subjects, Geriat. Med. (Japan)., 17, 1564
- Alberts, 1988, Lovastatin and simvastatin, Cah. Nutr. Diet., 23, 231
Cited by
Sorted by citations
Items 401–500 of 853
Min, S.-W., Jung, S.-H., Cho, K.-H., & Kim, D. (2008) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2008.16.4.364 · Cited by 17
Biotransformation of Compactin to Pravastatin by Actinomadura sp. 2966.
Peng, Y., Yashphe, J., & Demain, A. L. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.1032 · Cited by 17
Giordano, A., Romano, S., Monaco, M., Sorrentino, A., Corcione, N., Pace, A. L. D., Ferraro, P., Nappo, G., Polimeno, M., & Romano, M. F. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00490.2011 · Cited by 17
Agunloye, O. M., & Oboh, G. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12604 · Cited by 17
Erol, A. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.014 · Cited by 17
Section Review—Cardiovascular & Renal: Emerging Therapies in Atherosclerosis
Krause, B. R., Sliskovic, D. R., & Bocan, T. M. A. (1995) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.4.5.353 · Cited by 17
Chemoenzymatic Synthesis of δ‐Keto β‐Hydroxy Esters as Useful Intermediates for Preparing Statins
Tartaggia, S., Fogal, S., Motterle, R., Ferrari, C., Pontini, M., Aureli, R., & Lucchi, O. D. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201600268 · Cited by 16
Lorza‐Gil, E., de Souza, J. C., García‐Arévalo, M., Vettorazzi, J. F., Marques, A. C., Salerno, A. G., Trigo, J. R., & Oliveira, H. C. F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27932 · Cited by 16
Cyclodextrin-Based Supramolecular Complexes of Osteoinductive Agents for Dental Tissue Regeneration
Terauchi, M., Tamura, A., Arisaka, Y., Masuda, H., Yoda, T., & Yui, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020136 · Cited by 16
Song, X., Chen, Y.-Y., Liu, W., Cong, L., Zhang, J., Zhang, Y., & Zhang, Y. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5132 · Cited by 16
Wang, H., Lu, Z., Li, Y., Liu, T., Zhao, L., Gao, T., Lu, X., & Gao, B. (2023) · Molecules · doi:10.3390/molecules28062643 · Cited by 17
Statins redux: A re-assessment of how statins lower plasma cholesterol
Raghow, R. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.230 · Cited by 16
Atherothrombosis and Coronary Artery Disease
Goldschmidt, P. J., Lopes, N. H. M., Crawford, L. E., & Becker, R. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50797-7 · Cited by 16
Clunn, G. F., Lymn, J., Schächter, M., & Hughes, A. D. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701299 · Cited by 16
Arntz, H.-R. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00251-8 · Cited by 16
Humphrey, A. J., & Beale, M. H. (2006) · doi:10.1002/9780470988558.ch3 · Cited by 16
Lin, C., Chang, Y., Liu, J., Chuang, M., & Chien, L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0202-x · Cited by 15
Papapoulos, S. E. (2020) · Bone · doi:10.1016/j.bone.2020.115244 · Cited by 16
Das, K. C., Hossain, M. U., Moniruzzaman, M., Salimullah, M., & Akhteruzzaman, S. (2022) · BioMed Research International · doi:10.1155/2022/4558867 · Cited by 15
Wu, J.-H., Wang, Q., Li, F., Shu, Y.-L., Chan, C.-O., Mok, D. K., & Chan, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/320304 · Cited by 15
Felice, B. D., Santillo, M., Serù, R., Damiano, S., Matrone, G., Wilson, R. R., & Mondola, P. (2004) · Gene Expression · doi:10.3727/000000004783992198 · Cited by 15
Is hypertriglyceridemia atherogenic?
Huet, F., Roubille, C., & Roubille, F. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000622 · Cited by 15
Maczek, C., Böck, G., Jürgens, G., Schönitzer, D., Dietrich, H., & Wick, G. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00011-4 · Cited by 15
Bastiaanse, E. M. L., Atsma, D. E., Kuijpers, M. M. C., & van der Laarse, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80308-0 · Cited by 15
Pak, V. V., Koo, M., Kwon, D. Y., Shakhidoyatov, K. M., & Yun, L. M. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.090 · Cited by 15
de Keyser, C. E., Eijgelsheim, M., Albert Hofman, D., Sijbrands, E. J. G., der Zee, A. H. M., van Duijn, C. M., Uitterlinden, A. G., Witteman, J. C. M., & Stricker, B. H. C. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.11 · Cited by 15
Update on lipid-lowering therapy and LDL-cholesterol targets
Wiviott, S. D., & Cannon, C. P. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0613 · Cited by 15
Felgines, C., Sérougne, C., Mathé, D., Mazur, A., & Lutton, C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00792-6 · Cited by 15
Petzinger, E., Nickau, L., Horz, J. A., Schulz, S., Wess, G., Enhsen, A., Falk, E., Baringhaus, K. H., Glombik, H., Hoffmann, A., et al. (1995) · Hepatology · doi:10.1002/hep.1840220629 · Cited by 15
Pappolla, M. A., Refolo, L. M., Sambamurti, K., Zambón, D., & Duff, K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240388 · Cited by 16
Dick, M., Jonak, P., & Leask, R. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.002 · Cited by 14
Jaśkiewicz, A., Pająk, B., Łabieniec-Watała, M., Palma, C. D., & Orzechowski, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050694 · Cited by 13
Berwal, M. K., Haldhar, S. M., Ram, C., Gora, J. S., Singh, D., & Samadia, D. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_390_20 · Cited by 14
Gelabert, R. C. (2004) · Revista Clínica Española · doi:10.1016/s0014-2565(04)71566-0 · Cited by 14
Mohammadi, A., Mirzaei, F., Moradi, M., Jamshidi, M., Yari, R., Ghiasvand, T., Rezaii, A., & Oshaghi, E. A. (2013) · Avicenna Journal of Medical Biochemistry · Cited by 14
Activity of rosuvastatin in tachyzoites of Toxoplasma gondii (RH strain) in HeLa cells
Sanfelice, R. A., Machado, L. F., Bosqui, L. R., Miranda-Sapla, M. M., Tomiotto‐Pellissier, F., Dalevedo, G. A., Ioris, D., Reis, G. F., Panagio, L. A., Navarro, I. T., et al. (2017) · Experimental Parasitology · doi:10.1016/j.exppara.2017.07.009 · Cited by 14
Pedoman Tatalaksana Dislipidemia PERKI 2013
Erwinanto, E., Santoso, A., Putranto, J. N., Tedjasukmana, P., Suryawan, R., Rifqi, S., & Kasiman, S. (2015) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v34i4.385 · Cited by 14
Takai, K., Nawate, Y., Okabayashi, T., Nakatsuji, H., Iida, A., & Tanabe, Y. (2009) · Tetrahedron · doi:10.1016/j.tet.2009.02.084 · Cited by 14
Genetic interaction networks mediate individual statin drug response in Saccharomyces cerevisiae
Busby, B. P., Niktab, E., Roberts, C. A., Sheridan, J. P., Coorey, N., Senanayake, D., Connor, L. M., Munkacsi, A. B., & Atkinson, P. H. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0112-5 · Cited by 15
Dietary modulators of statin efficacy in cardiovascular disease and cognition
Wang, H., Blumberg, J. B., Chen, C. ‐. O., Choi, S., Corcoran, M. P., Harris, S. S., Jacques, P. F., Kristo, A. S., Lai, C., Lamon‐Fava, S., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.04.001 · Cited by 14
Statin pharmacogenomics: what have we learned, and what remains unanswered?
Kajinami, K., Okabayashi, M., Sato, R., Polisecki, E. Y., & Schaefer, E. J. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191914.54439.b7 · Cited by 14
Statin response and pharmacokinetics variants
Kajinami, K., Masuya, H., Hoshiba, Y., Takeda, K., Sato, R., Okabayashi, M., & Schaefer, E. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1291 · Cited by 14
Turner, J., Minkoff, C. G., Martin, K. H., Misra, R., & Swenson, K. I. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1145 · Cited by 14
Jalal, M. M., Whyte, C. S., Coxon, F. P., & Mutch, N. J. (2023) · Platelets · doi:10.1080/09537104.2023.2206921 · Cited by 13
Ju, M., Zhang, J., Mai, T., Li, L., Gu, T., Liu, Y., & Gao, M. (2023) · LWT · doi:10.1016/j.lwt.2023.114949 · Cited by 14
Khoury, M. E., & Naim, H. Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1335458 · Cited by 13
Troiani, V., Cluzeau, J., & Časar, Z. (2011) · Organic Process Research & Development · doi:10.1021/op100341m · Cited by 13
Deligiorgi, M. V., Panayiotidis, M. I., Siasos, G., & Trafalis, D. T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200123151132 · Cited by 13
Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
Díaz-Zagoya, J. C., Marín-Medina, A., Zetina‐Esquivel, A. M., Blé‐Castillo, J. L., Castell-Rodríguez, A. E., Juárez‐Rojop, I. E., & Miranda‐Zamora, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-95140-1 · Cited by 13
Tang, S., Men, P., Zhang, W., Li, H., Li, Z., Huang, X., & Lü, X. (2022) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2022.103690 · Cited by 13
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19166 · Cited by 13
Teramoto, T., Sawada, T., Iwamoto, K., & Daida, H. (2012) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.02.002 · Cited by 13
Issandou, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.012 · Cited by 13
Is hypertriglyceridemia atherogenic?
Roubille, F., Sultan, A., Huet, F., Leclercq, F., Macia, J., Gervasoni, R., Delseny, D., Akodad, M., & Roubille, C. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.08.009 · Cited by 13
Methyl palmitate: a novel product of the Medfly (Ceratitis capitata) corpus allatum
Moshitzky, P., Miloslavski, I., Aizenshtat, Z., & Applebaum, S. W. (2003) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2003.06.008 · Cited by 13
Belo, R. S., Jamieson, J., & Wright, J. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925694 · Cited by 13
Unique Properties of the Large Antigen of Hepatitis Delta Virus
Moraleda, G., Seeholzer, S. H., Bichko, V. V., Dunbrack, R. L., Otto, J. C., & Taylor, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7147-7152.1999 · Cited by 13
Pathophysiology of plaque instability: Insights at the genomic level
Lopes, N. H. M., Vasudevan, S. S., Alvarez, R., Binkley, P. F., & Goldschmidt, P. J. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.125097 · Cited by 13
Asymmetric Hydrogenation of C O and C N Bonds in Stereoselective Synthesis
Andrushko, N. V., & Andrushko, V. (2013) · doi:10.1002/9781118596784.ssd030 · Cited by 13
Is there a role for statins in fungal infections?
Bergman, P. W., & Björkhem-Bergman, L. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.856755 · Cited by 12
Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics
Maurya, S. K., Chaudhri, S., Kumar, S., & Gupta, S. (2025) · Pharmaceutical Research · doi:10.1007/s11095-024-03811-1 · Cited by 14
Lee, S. M., Park, N. S., Jin, B. R., Kang, H.-S., Jung, J. H., & Park, E. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.214 · Cited by 12
Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits
Cheng, D., Wang, Y., Gao, S., Wang, X., Sun, W., Bai, L., Cheng, G., Chu, Y., Zhao, S., & Liu, E. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.03.007 · Cited by 12
Attia, Y. A., Hamid, A., de Oliveira, M., Kamel, K. I., Qota, E. M. A., Al‐Harthi, M. A., & Sadaka, T. A. (2018) · Journal of Animal and Feed Sciences · doi:10.22358/jafs/80344/2018 · Cited by 12
Evaluation of antiviral effect of atorvastatin on H1N1 infection in MDCK cells
Mehrbod, P. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr12.1011 · Cited by 12
Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation
Portal, V. L., Moriguchi, E. H., Vieira, J. L. D. C., Schio, S. M., Mastalir, E. T., Buffé, F., Bortolini, E. B., Brüch, R. S., & Rodrigues, R. (2003) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2003000200004 · Cited by 12
Li, J. J. (2013) · Drug Discovery · doi:10.1002/9781118354483.ch1 · Cited by 12
Transcriptome analysis of adipose tissue and muscle of Laiwu and Duroc pigs
Wu, J., Yu, F., Di, Z., Bian, L., Yang, J., Wang, L., Jiang, Q., Yin, Y., & Zhang, L. (2024) · Animal nutrition · doi:10.1016/j.aninu.2023.12.012 · Cited by 12
Wei, L., Zheng, Y., Sun, J., Wang, P., Tao, T., Li, Y., Chen, X., Sang, Y., Chong, D., Zhao, W. H., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015020 · Cited by 11
Treatment of dyslipidaemia in childhood
Kusters, D. M., Vissers, M. N., Wiegman, A., Kastelein, J. J. P., & Hutten, B. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003592169 · Cited by 11
Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development
Kandel, S. E., Wienkers, L. C., & Lampe, J. N. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00022-5 · Cited by 12
Statins and the cholesterol mortality paradox
Nunes, J. P. L. (2016) · Scottish Medical Journal · doi:10.1177/0036933016681913 · Cited by 11
SREBP Plays a Regulatory Role in LH/hCG Receptor mRNA Expression in Human Granulosa-Lutein Cells
Li, Y., Guo, X., Gulappa, T., Menon, B., & Menon, K. M. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00913 · Cited by 11
Cholesterol: Can’t Live With It, Can’t Live Without It
Pownall, H. J., & Gotto, A. M. (2019) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-15-1-9 · Cited by 11
Ramani, K. P., Singh, S., Maurya, A. R., Deshmukh, P. K., Chatap, V. K., & Bari, S. B. (2012) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(12)50089-4 · Cited by 11
Hepatolipidemic Effects of Naringenin in High Cornstarch- Versus High Coconut Oil-Fed Rats
Wood, N. (2004) · Journal of Medicinal Food · doi:10.1089/jmf.2004.7.315 · Cited by 11
HANSEN, P. S., Meinertz, H., Gerdes, L. U., Klausen, I. C., & Færgeman, O. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00577757 · Cited by 11
Lyons, K., & Harbinson, M. (2009) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2009.425 · Cited by 11
Matsuda, T., Toyohira, Y., Ueno, S., Tsutsui, M., & Yanagihara, N. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139659 · Cited by 11
Cerivastatin: a cellular and molecular drug for the future?
Siegel-Axel, D. I. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300010 · Cited by 11
Alternative approaches to cholesterol-lowering therapy
Grundy, S. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02797-2 · Cited by 11
[5] Assays for inhibitors of CAAX farnesyltransferase in Vitro and in intact cells
James, G. L., Brown, M. S., & Goldstein, J. L. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(95)55007-0 · Cited by 11
Winkler, K. E. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00051-9 · Cited by 11
Yuan, S., Zhuang, S., Qiao, Y., Wu, Q., Ma, Y., Chen, S., Liu, L., Yan, Y., & Gao, Z. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c00357 · Cited by 10
Morales-Villegas, E., Sciascio, G. D., & Briguori, C. (2011) · International Journal of Hypertension · doi:10.4061/2011/904742 · Cited by 9
Simvastatin increases excitability in the hippocampus via a PI3 kinase-dependent mechanism
Métais, C., Hughes, B., & Herron, C. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.023 · Cited by 10
Trenin, A. S. (2013) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162013060095 · Cited by 10
Statins and vitamin D: a friendly association in pre-dialysis patients
Neves, P. L., Guedes, A. M., Cabrita, A., Pinho, A., Baptista, A., Morgado, E., Faísca, M., Carrasqueira, H., & Silva, A. P. (2009) · International Urology and Nephrology · doi:10.1007/s11255-009-9634-x · Cited by 10
The Real Code of Leonardo da Vinci
Ose, L. (2008) · Current Cardiology Reviews · doi:10.2174/157340308783565401 · Cited by 10
Zhang, Y., Chan, J. F., & Cummins, C. L. (2009) · Clinical Lipidology · doi:10.2217/17584299.4.1.29 · Cited by 10
Emerging Targets for the Treatment of Dyslipidemia
Tavridou, A., Ragia, G., & Manolopoulos, V. G. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794927757 · Cited by 10
Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro
Wang, S., Li, M., Luo, X., Yu, L., Nie, Z., Liu, Q., An, X., Ao, Y., Liu, Q., Chen, J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00247 · Cited by 10
Treatment for Dementia: Learning from Breakthroughs for Other Conditions
Taylor, J., Marjanovic, S., Nolte, E., Pollitt, A., & Rubin, J. (2015) · Rand health quarterly · doi:10.7249/rhq-06-01-05 · Cited by 10
Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
Pak, V. V., Kwon, D. Y., Khojimatov, O. K., Pak, A. V., & Сагдуллаев, Ш. Ш. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10221-z · Cited by 10
Antioxidants status and physiological responses to early and late heat stress in two rabbit breeds
Madkour, M., Shakweer, W. M. E.-S., Hashem, N. M., Aboelazab, O., Younis, E., Azeem, N. A. A. E., & Shourrap, M. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13781 · Cited by 10
Marcuzzi, A., Piscianz, E., Loganes, C., Brumatti, L. V., Knowles, A., Bilel, S., Tommasini, A., Bortul, R., & Zweyer, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010047 · Cited by 11
Effect of triton X-100 on compactin production fromPenicillium citrinum
Choi, D., Cho, K.-A., Cha, W. S., & Ryu, S. R. (2004) · Biotechnology and Bioprocess Engineering · doi:10.1007/bf02942288 · Cited by 10
Is There Treatment for “Genetic” Disease?
Scriver, C. R., & Treacy, E. P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2907 · Cited by 10
Yano, T., Kawano, H., Yamashita, M., Mizuguchi, K., Mochizuki, H., & Iwamoto, T. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00859-x · Cited by 10
Li, S., Dudczak, R., Koller, E., Baghestanian, M., Ghannadan, M., Minar, E., Pirich, C., Angelberger, P., Virgolini, I. J., Li, M., et al. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0668-1 · Cited by 10
Metadata
- Authors
- Endo, A.
- Corresponding author
- Endo, A
- ORCID
- Endo, A
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1992-11
- Volume
- 33
- Issue
- 11
- Pages
- 1569-1582
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2148463229
- Cited by
- 847
- References
- 114
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 31 · 2023: 22 · 2022: 25 · 2021: 26 · 2020: 23 · 2019: 20 · 2018: 35 · 2017: 28 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 43 · 2012: 35
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Keywords
- statins, cholesterol-lowering drugs, drug discovery, drug development
- MeSH terms
- Animals, Anticholesteremic Agents, Humans, Hypercholesterolemia, Lovastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review